id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-295329-y7rx3ky4	Mattioli, Francesco	Tracheostomy in the COVID-19 pandemic	2020-04-22		.txt	text/plain	1375	89	49	The mortality appears to be around 2%; early published data indicate 25.9% with COVID-19 pneumonia required intensive care unit (ICU) admission and 20.1% developed acute respiratory distress syndrome (ARDS) [1, 2] . During the last 2 weeks, we performed 28 tracheostomies on patients with ARDS due to COVID-19 infection who were treated with IMV. In this early phase, aggressive treatments and intensive care are needed for critically ill patients and tracheostomy could not result in improvement in hypoxia, multiple organ dysfunction, virus clearance, and in shorter duration of IMV. In our experience, several delayed (> 14 OTI days) tracheostomies were performed especially in the first-affected intubated cases who required re-intubation without clinical improvement, and in case of lack of ICU places. In the context of prolonged IMV required in COVID-19 experience, tracheostomy should be suggested to avoid potential tracheal damages within 7 and 14 days.	./cache/cord-295329-y7rx3ky4.txt	./txt/cord-295329-y7rx3ky4.txt